{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:53:55Z","timestamp":1791615235052,"version":"4.3.4"},"reference-count":47,"publisher":"American Society of Hematology","issue":"24","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,26]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in adults, but first-line immunochemotherapy fails to produce a durable response in about one-third of the patients. Because tumor cells often reprogram their metabolism, we investigated the importance of glutaminolysis, a pathway converting glutamine to generate energy and various metabolites, for the growth of DLBCL cells. Glutaminase-1 (GLS1) expression was robustly detected in DLBCL biopsy samples and cell lines. Both pharmacological inhibition and genetic knockdown of GLS1 induced cell death in DLBCL cells regardless of their subtype classification, whereas primary B cells remained unaffected. Interestingly, GLS1 inhibition resulted not only in reduced levels of intermediates of the tricarboxylic acid cycle but also in a strong mitochondrial accumulation of reactive oxygen species. Supplementation of DLBCL cells with \u03b1-ketoglutarate or with the antioxidant \u03b1-tocopherol mitigated oxidative stress and abrogated cell death upon GLS1 inhibition, indicating an essential role of glutaminolysis in the protection from oxidative stress. Furthermore, the combination of the GLS1 inhibitor CB-839 with the therapeutic BCL2 inhibitor ABT-199 not only induced massive reactive oxygen species (ROS) production but also exhibited highly synergistic cytotoxicity, suggesting that simultaneous targeting of GLS1 and BCL2 could represent a novel therapeutic strategy for patients with DLBCL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023010964","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T20:04:55Z","timestamp":1699387495000},"page":"7433-7444","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":29,"title":["Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative\u00a0stress"],"prefix":"10.1182","volume":"7","author":[{"given":"Beatriz","family":"Gomez Solsona","sequence":"first","affiliation":[{"name":"1Interfaculty Institute of Biochemistry, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Horn","sequence":"additional","affiliation":[{"name":"2Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany"},{"name":"3Dr. Margarete Fischer Bosch Institute of Clinical Pharmacology, University of T\u00fcbingen, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Schmitt","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendan","family":"Xu","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bucher","sequence":"additional","affiliation":[{"name":"1Interfaculty Institute of Biochemistry, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Heinrich","sequence":"additional","affiliation":[{"name":"1Interfaculty Institute of Biochemistry, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Kalmbach","sequence":"additional","affiliation":[{"name":"2Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany"},{"name":"3Dr. Margarete Fischer Bosch Institute of Clinical Pharmacology, University of T\u00fcbingen, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kreienkamp","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"Franke","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wimmers","sequence":"additional","affiliation":[{"name":"1Interfaculty Institute of Biochemistry, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurentz","family":"Schuhknecht","sequence":"additional","affiliation":[{"name":"5Institute of Molecular Systems Biology, Department of Biology, ETH Z\u00fcrich, Z\u00fcrich, Switzerland"},{"name":"6Department of Biomedicine, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"7Institute of Pathology, University of W\u00fcrzburg and Comprehensive Cancer Center Mainfranken, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Zampieri","sequence":"additional","affiliation":[{"name":"5Institute of Molecular Systems Biology, Department of Biology, ETH Z\u00fcrich, Z\u00fcrich, Switzerland"},{"name":"6Department of Biomedicine, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"2Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lenz","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Schulze-Osthoff","sequence":"additional","affiliation":[{"name":"1Interfaculty Institute of Biochemistry, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"8German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"9Cluster of Excellence iFIT (EXC 2180) \u201cImage-Guided and Functionally Instructed Tumor Therapies,\u201d University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Hailfinger","sequence":"additional","affiliation":[{"name":"4Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"issue":"20","key":"2023122214370180600_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"14","key":"2023122214370180600_bib2","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2010.33.3252","article-title":"Pathogenesis of non-Hodgkin's lymphoma","volume":"29","author":"Nogai","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"6769","key":"2023122214370180600_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"25","key":"2023122214370180600_bib4","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"2023122214370180600_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A\u00a0probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"17","key":"2023122214370180600_bib6","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A\u00a0gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2023122214370180600_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"15","key":"2023122214370180600_bib8","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"2023122214370180600_bib9","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","article-title":"Genetics of diffuse large B-cell lymphoma","volume":"131","author":"Pasqualucci","year":"2018","journal-title":"Blood"},{"issue":"22","key":"2023122214370180600_bib10","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1200\/JCO.2016.70.3660","article-title":"Clinical impact of the cell-of-origin classification and the MYC\/ BCL2 dual expresser status in diffuse large B-cell lymphoma treated within prospective clinical trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group","volume":"35","author":"Staiger","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"2023122214370180600_bib11","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.bbamcr.2015.12.017","article-title":"Glutamine transporters in mammalian cells and their functions in physiology and cancer","volume":"1863","author":"Bhutia","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"7239","key":"2023122214370180600_bib12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"issue":"5","key":"2023122214370180600_bib13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ccell.2018.04.002","article-title":"The GSK3 signaling axis regulates adaptive glutamine metabolism in lung squamous cell carcinoma","volume":"33","author":"Momcilovic","year":"2018","journal-title":"Cancer Cell"},{"key":"2023122214370180600_bib14","doi-asserted-by":"crossref","first-page":"589508","DOI":"10.3389\/fonc.2020.589508","article-title":"Targeting glutaminolysis: new perspectives to understand cancer development and novel strategies for potential target therapies","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"2023122214370180600_bib15","first-page":"355","article-title":"Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer","volume":"8","author":"Saha","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"6235","key":"2023122214370180600_bib16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","author":"GTEx Consortium","year":"2015","journal-title":"Science"},{"issue":"16","key":"2023122214370180600_bib17","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1073\/pnas.1002459107","article-title":"Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species","volume":"107","author":"Suzuki","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"2023122214370180600_bib18","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.1001006107","article-title":"Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function","volume":"107","author":"Hu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2023122214370180600_bib19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4161\/cc.24478","article-title":"p63 regulates glutaminase 2 expression","volume":"12","author":"Giacobbe","year":"2013","journal-title":"Cell Cycle"},{"issue":"22","key":"2023122214370180600_bib20","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.4161\/cc.26771","article-title":"GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation","volume":"12","author":"Velletri","year":"2013","journal-title":"Cell Cycle"},{"issue":"4","key":"2023122214370180600_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2174\/1566524011313040005","article-title":"Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer","volume":"13","author":"Mat\u00e9s","year":"2013","journal-title":"Curr Mol Med"},{"issue":"13","key":"2023122214370180600_bib22","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3390\/molecules24132367","article-title":"The metabolomic profile of lymphoma subtypes: a pilot study","volume":"24","author":"Barberini","year":"2019","journal-title":"Molecules"},{"issue":"9","key":"2023122214370180600_bib23","first-page":"1582","article-title":"B\u00a0cell lymphoma with different metabolic characteristics show distinct sensitivities to metabolic inhibitors","volume":"9","author":"Liu","year":"2018","journal-title":"J\u00a0Cancer"},{"key":"2023122214370180600_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","article-title":"Glutaminolysis: a hallmark of cancer metabolism","volume":"19","author":"Yang","year":"2017","journal-title":"Annu Rev Biomed Eng"},{"issue":"49","key":"2023122214370180600_bib25","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023122214370180600_bib26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-biochem-061516-044724","article-title":"2-oxoglutarate-dependent oxygenases","volume":"87","author":"Islam","year":"2018","journal-title":"Annu Rev Biochem"},{"issue":"7274","key":"2023122214370180600_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"issue":"7598","key":"2023122214370180600_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature17393","article-title":"Reductive carboxylation supports redox homeostasis during anchorage-independent growth","volume":"532","author":"Jiang","year":"2016","journal-title":"Nature"},{"issue":"7381","key":"2023122214370180600_bib29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature10602","article-title":"Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia","volume":"481","author":"Metallo","year":"2011","journal-title":"Nature"},{"issue":"19","key":"2023122214370180600_bib30","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1073\/pnas.1003428107","article-title":"Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity","volume":"107","author":"Weinberg","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2023122214370180600_bib31","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"2023122214370180600_bib32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fonc.2018.00632","article-title":"Glutaminolysis mediated by MALT1 protease activity facilitates PD-L1 expression on ABC-DLBCL cells and contributes to their immune evasion","volume":"8","author":"Xia","year":"2018","journal-title":"Front Oncol"},{"issue":"8","key":"2023122214370180600_bib33","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1002\/jcp.28091","article-title":"The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML","volume":"234","author":"Nguyen","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"issue":"3","key":"2023122214370180600_bib34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/blood.2020009081","article-title":"Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production","volume":"138","author":"Lee","year":"2021","journal-title":"Blood"},{"issue":"6","key":"2023122214370180600_bib35","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1159\/000505892","article-title":"The spectrum of MYC alterations in diffuse large B-cell lymphoma","volume":"143","author":"Xia","year":"2020","journal-title":"Acta Haematol"},{"issue":"47","key":"2023122214370180600_bib36","doi-asserted-by":"crossref","first-page":"19946","DOI":"10.1073\/pnas.0907511106","article-title":"Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma","volume":"106","author":"Hailfinger","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2023122214370180600_bib37","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1084\/jem.20091167","article-title":"Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells","volume":"206","author":"Ferch","year":"2009","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"2023122214370180600_bib38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/ars.2011.4391","article-title":"The cystine\/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities","volume":"18","author":"Lewerenz","year":"2013","journal-title":"Antioxid Redox Signal"},{"issue":"7443","key":"2023122214370180600_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"issue":"5","key":"2023122214370180600_bib40","doi-asserted-by":"crossref","first-page":"101116","DOI":"10.1016\/j.isci.2020.101116","article-title":"NADPH and glutathione redox link TCA cycle activity to endoplasmic reticulum homeostasis","volume":"23","author":"Gansemer","year":"2020","journal-title":"iScience"},{"issue":"13","key":"2023122214370180600_bib41","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1158\/1078-0432.CCR-18-3223","article-title":"Targeting glutamine metabolism and redox state for leukemia therapy","volume":"25","author":"Gregory","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2023122214370180600_bib42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2020.12.038","article-title":"Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models","volume":"502","author":"Wicker","year":"2021","journal-title":"Cancer Lett"},{"issue":"10","key":"2023122214370180600_bib43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood.2020009404","article-title":"Dimethyl fumarate induces ferroptosis and impairs NF-\u03baB\/STAT3 signaling in DLBCL","volume":"138","author":"Schmitt","year":"2021","journal-title":"Blood"},{"issue":"4","key":"2023122214370180600_bib44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood-2016-12-759621","article-title":"BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation","volume":"130","author":"Tsuyama","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2023122214370180600_bib45","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/leu.2015.99","article-title":"Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1","volume":"29","author":"Li","year":"2015","journal-title":"Leukemia"},{"key":"2023122214370180600_bib46","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fphar.2019.00697","article-title":"Efficacy and safety of Bcl-2 inhibitor venetoclax in hematological malignancy: a systematic review and meta-analysis of clinical trials","volume":"10","author":"Li","year":"2019","journal-title":"Front Pharmacol"},{"issue":"6","key":"2023122214370180600_bib47","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3324\/haematol.2022.281538","article-title":"Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma","volume":"108","author":"Li","year":"2023","journal-title":"Haematologica"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/24\/7433\/2177819\/blooda_adv-2023-010964-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/24\/7433\/2177819\/blooda_adv-2023-010964-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T14:37:27Z","timestamp":1703255847000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/24\/7433\/498650\/Inhibition-of-glutaminase-1-in-DLBCL-potentiates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":47,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023,12,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010964","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]}}}